Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Mount Sinai Health System operates one of the largest academic medical systems in New York City. It delivers comprehensive patient care across seven hospital campuses and over 400 outpatient locations. Its Icahn School of Medicine ranks among top U.S. institutions for NIH funding and biomedical innovation. The system conducts extensive basic science and translational research but does not itself commercialize drugs or devices as a biotech/pharma would.
Recent highlights include pioneering work in AI-driven healthspan science and immunological mapping in dermatology.
Clinical results are published through affiliated hospitals’ outcomes data rather than centralized drug development pipelines.
Pipeline breadth/pipeline/programs/therapeutic_areas fields below reflect its role as an integrated provider/researcher rather than product developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mount Sinai Health System.